These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [SUPERADDITIVE EFFECTS IN COMBINATION OF THE SUBSTANCES OF THE CURARE GROUP]. SEEGER R. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Feb 02; 250():42-50. PubMed ID: 14256440 [No Abstract] [Full Text] [Related]
10. Experimental and clinical experiences with a new muscle relaxant Ro 4-3816, diallyl-nor-toxiferine. LUND I, STOVNER J. Acta Anaesthesiol Scand; 1962 Feb 02; 6():85-97. PubMed ID: 14467347 [No Abstract] [Full Text] [Related]
13. DIALLYL NOR-TOXIFERINE -- A NEW RELAXANT. TAY G. Singapore Med J; 1963 Jun 02; 3():90-2. PubMed ID: 14046970 [No Abstract] [Full Text] [Related]
14. A comparative study of two different muscle relaxants, d-tubocurarine and a derivactive of toxiferine (Ro 4-3816). JORGENSEN AB, LYSGAARD A. Acta Anaesthesiol Scand Suppl; 1962 Jun 02; 12():86-7. PubMed ID: 13964907 [No Abstract] [Full Text] [Related]
15. [On the pharmacology of diallyl-bis-nor-toxiferine (alloferine)]. Hürlimann A, Bächtold HP. Bull Schweiz Akad Med Wiss; 1967 Jul 02; 22(5):511-5. PubMed ID: 5598883 [No Abstract] [Full Text] [Related]
16. [CURARIZING ACTIVITY OF 3-BETA,20-ALPHA-BISTRIMETHYLAMMONIUM-5-ALPHA-PREGNANE DICHLORIDE (MALOUETINE) AND OF ITS STEREOISOMERS]. HUU LAINE FK, PINTO SCOGNAMIGLIO W. Arch Int Pharmacodyn Ther; 1964 Jan 01; 147():209-19. PubMed ID: 14116930 [No Abstract] [Full Text] [Related]
17. [Research on the comparative cumulative effects of d-tubocurarine, toxiferine and diallyl-nor-toxiferine]. HEROLD M, KABACOFF O, CAHN J. Agressologie; 1961 Jan 01; 2():375-82. PubMed ID: 13906785 [No Abstract] [Full Text] [Related]
18. SOME CHEMICAL ASPECTS OF NEUROMUSCULAR BLOCK. STENLAKE JB. Prog Med Chem; 1963 Jan 01; 19():1-51. PubMed ID: 14146301 [No Abstract] [Full Text] [Related]